XXXXXXXXX XXXXXXXX XXXXXX (XX) 2023/543
xx xxx 9.&xxxx;xxxxxx 2023,
xxxxxx xx xxxx xxxxxxxxx xxxxxxxx (XX) x.&xxxx;686/2012, pokud xxx x&xxxx;xxxxxxxxx xxxxxxxxx xxxxxxxx látek, jejichž xxxxxxxx xxxxxx x&xxxx;xxxxxx xx 31. ledna 2029 do 1.&xxxx;xxxxx&xxxx;2035, členským xxxxxx xxx xxxxx xxxxxxx xxxxxxxx
(Xxxx x&xxxx;xxxxxxxx xxx XXX)
XXXXXXXX KOMISE,
s ohledem xx Xxxxxxx x&xxxx;xxxxxxxxx Xxxxxxxx xxxx,
x&xxxx;xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Rady (XX) x.&xxxx;1107/2009 ze xxx 21.&xxxx;xxxxx&xxxx;2009 x&xxxx;xxxxxxx xxxxxxxxx na ochranu xxxxxxx xx trh x&xxxx;x&xxxx;xxxxxxx xxxxxxx Xxxx&xxxx;79/117/XXX x&xxxx;91/414/XXX&xxxx;(1), a zejména xx xxxxxx&xxxx;19 xxxxxxxxx xxxxxxxx,
xxxxxxxx x&xxxx;xxxxx xxxxxxx:
|
(1) |
Xxxxxxxxx xxxxxxxx Xxxxxx (EU) x.&xxxx;686/2012&xxxx;(2) xxxxxxxxx xxxxxxxxx účinných xxxxx xxx xxxxx xxxxxxx obnovení zpravodajskému xxxxxxxxx státu x&xxxx;xxxxxxxxxxxxxxxxxxx xxxxxxxxx státu. Xxxxxxx xxxxxxxxx xxxxxxxx xxxxx, xxxxxxx xxxxxxxx xxxxxx x&xxxx;xxxxxx xx 31.&xxxx;xxxxx&xxxx;2029 xx 1.&xxxx;xxxxx&xxxx;2035, xxxxx xxxxxx zpravodajskému xxxx xxxxxxxxxxxxxxxxxxx členskému xxxxx xxxxxxxxx, je xxxxxxx xxxx přidělení xxxxxxx. |
|
(2) |
Xxxx xxxxxxxxx by xxxx xxx xxxxxxxxx způsobem, xxxxx zajistí xxxxxxxx xxxxxxxxx povinností x&xxxx;xxxxxxxx xxxx xxxxxxxxx státy. |
|
(3) |
Prováděcí xxxxxxxx (XX) x.&xxxx;686/2012 xx xxxxx xxxx xxx xxxxxxxxxxxxx způsobem xxxxxxx. |
|
(4) |
Xxxxxxxx xxxxxxxxx xxxxx xxxxxxxxx jsou x&xxxx;xxxxxxx xx stanoviskem Xxxxxxx xxxxxx xxx xxxxxxxx, xxxxxxx, xxxxxxxxx x&xxxx;xxxxxx, |
XXXXXXX XXXX NAŘÍZENÍ:
Xxxxxx&xxxx;1
Xxxxxxxxx xxxxxxxx (XX) x.&xxxx;686/2012 xx xxxx x&xxxx;xxxxxxx s přílohou tohoto xxxxxxxx.
Článek 2
Toto xxxxxxxx xxxxxxxx x&xxxx;xxxxxxxx xxxxxxxx xxxx xx xxxxxxxxx x&xxxx;Xxxxxxx xxxxxxxx Evropské xxxx.
Toto nařízení xx xxxxxxx x&xxxx;xxxxx xxxxxxx x&xxxx;xxxxx xxxxxxxxxx xx xxxxx členských xxxxxxx.
X&xxxx;Xxxxxxx xxx 9.&xxxx;xxxxxx 2023.
Xx Xxxxxx
xxxxxxxxxxx
Xxxxxx VON XXX XXXXX
(1)&xxxx;&xxxx;Xx.&xxxx;xxxx.&xxxx;X&xxxx;309, 24.11.2009, x.&xxxx;1.
(2)&xxxx;&xxxx;Xxxxxxxxx xxxxxxxx Komise (EU) x.&xxxx;686/2012 xx dne 26.&xxxx;xxxxxxxx&xxxx;2012, xxxxxx se xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxx xxxxxxxx státům xxx účely xxxxxxx xxxxxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;200, 27.7.2012, x.&xxxx;5).
XXXXXXX
X&xxxx;xxxxxxx prováděcího nařízení (XX) x.&xxxx;686/2012 se xxxxxxxx xxxx xxxx X, xxxxx xxx:
„Xxxx X
Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxx, jejichž povolení xxxxxx x&xxxx;xxxxxx xx 31.&xxxx;xxxxx&xxxx;2029 xx 1. října 2035
|
Účinná xxxxx |
Xxxxxxxxxxxx xxxxxxx xxxx |
Xxxxxxxxxxxxxxxxx xxxxxxx xxxx |
|
1-xxxxxxxxxxxxxxxxx |
XX |
XX |
|
2,4-X |
XX |
XX |
|
2,4-XX |
XX |
XX |
|
XXX-XX 56 |
FR |
PT |
|
Acetamiprid |
DE |
ES |
|
Acibenzolar-S-methyl |
ES |
BE |
|
Ampelomyces xxxxxxxxxx kmen XX10 |
XX |
XX |
|
Xxxxxxxx xxxxxxxxxxxxxxxxx xxxx XXX24 |
XX |
XX |
|
Xxxxxxxx xxxxxxxx xxxx&xxxx;XXX/XX03 |
XX |
XX |
|
Xxxxxxxxx xxxxxxxx xxxx 203 |
DK |
NL |
|
Beauveria xxxxxxxx xxxx XXX389521 |
XX |
XX |
|
Xxxxxxxxx xxxxxxxx xxxx XXXX 5339 |
XX |
XX |
|
Xxxxxxxx xxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxx |
XX |
XX |
|
Xxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx xxxxx kmen X1446 |
XX |
XX |
|
Xxxxxxxxxxxx minitans xxxx&xxxx;XXX/X/91-08 |
XX |
XX |
|
XXX-XXX |
XX |
XX |
|
Xxxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx-X |
XX |
XX |
|
Xxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxx xxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxx xxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxx-xxxxxx |
XX |
XX |
|
Xxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx |
XX |
XX |
|
Xxxxxx xxxxxxxxxxx xxxx Xxxxxx 97 |
XX |
XX |
|
Xxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxx-xxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxx |
XX |
XX |
|
Xxxxxxxxx-X |
XX |
XX |
|
Xxxxx xxxxxxx xxxxxx mírný xxxxxx VC1 |
FR |
DE |
|
Virus mozaiky xxxxxx xxxxx xxxxxx XX1 |
XX |
XX |
|
Xxxxxxxxx xxxxxxxxxx Pn1 |
NL |
DK |
|
Virus xxxxxxx xxxxxx xxxx XX2 izolát 1906 |
XX |
XX |
|
Xxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxx xxxxxxxx xxxx XXX XX 410.3 |
EE |
FI |
|
Phlebiopsis xxxxxxxx xxxx XXX 1835 |
XX |
XX |
|
Xxxxxxxxxxx xxxxxxxx kmen VRA 1984 |
XX |
XX |
|
Xxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxx-xxxxx |
XX |
XX |
|
Xxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxx xxxxxxxxxx xxxx XXX02 |
XX |
XX |
|
Xxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxxxxx xxxxx |
XX |
XX |
|
Xxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxx-xxxxxx |
XX |
XX |
|
Xxxxxxxxx-xxxxxx |
XX |
XX |
|
Xxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxx atroviride xxxx XX1 |
XX |
XX |
|
Xxxxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx xxxx-xxxxx xxxx XXX850 |
XX |
XX |
|
Xxxxxxx |
XX |
XX“ |